Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹113 Cr₹109 Cr₹40 Cr₹31 Cr₹61 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹113 Cr based on Mar2026 Standalone results.
Year Revenue
Mar2026₹113 Cr
Mar2025₹109 Cr
Mar2024₹40 Cr
Mar2023₹31 Cr
Mar2022₹61 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2026 ₹113 Cr
3.37
Mar2025 ₹109 Cr
175.72
Mar2024 ₹40 Cr
27.93
Mar2023 ₹31 Cr
-48.80
Mar2022 ₹61 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹213.8 Cr -4.8% 19.7% -26.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-4.8%

19.7%

-26.2%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses